This article provides information about mucosate and its application.
Content
Mukosat is a medication that regulates the metabolism in cartilage. Read more about the drug - in the article.
Mukosat: Instructions for use
Active Ingredient Mukosata - sodium chondroitin sulfate: 1 ml - 100 mg. Chondroitin sulfate is a macromolecule belonging to the family of glycosaminoglycans, known for its precious structural role of extracellular matrix.
- Chondroitin sulfate extracted from the cartilage rings of the cattle or pig trachea is a valuable agent for joint inflammation.
- Molecular mechanisms are not yet fully known, chondroitin sulfate can improve the functionality of the joints affected by inflammatory conditions, preventing degeneration.
Excipients: Water for injection and gasoline alcohol.
Mukosat: Indications for use
Chondroitin sulfate is a macromolecule belonging to the category of glycosaminoglycans. These molecules fall into the normal structure of the extracellular matrix of connective tissues, especially in the structure of the articular cartilage.
The protein gives the joint cartilage a certain flexibility and resistance to loads, as well as the ability to absorb strokes and injuries.
When the intra -articular content of chondroitin, hyaluronic acid and other molecules, such as glucosamine, decreases, the compound loses the aforementioned properties, inflammating and degenerating.
For these reasons, the use of chondroitin sulfate can:
- contribute to the structural and functional maintenance of the joint.
- show a certain chondro -protective activity.
- reduce pain in degeneration diseases, such as osteoarthritis.
- reduce the inflammatory process.
- improve joint mobility.
Mukosat is used to treat degenerative diseases of the spine and joints.
Properties and effectiveness of mucosate
Numerous studies show not unanimous results. Having examined the possible role of sulfate chondroitin separately or in combination with other molecules such as glucosamine, in controlled joint degeneration for inflammatory diseases, such as osteoarthritis, scientists have proven that the use of the drug led to improvements in the coronary artery, improving bloody lesions and reducing the concentration of cholesterol in the blood .
In some statistically significant clinical trials, the corresponding integration of chondroitin sulfate will have:
- Reducing joint pain in the knee with osteoarthritis.
- Improved mobility of the joint involved in the inflammatory process.
- Controlled functional and structural degeneration of the joint.
- Reducing the use of non -steroidal anti -inflammatory drugs.
Mukosat: dosage and treatment
Mukosat is administered intramuscularly. The initial dose is 1 ml with a frequency every other day. In the case of good tolerance of mucosate, starting with the 4th injection, the dose is increased to 2 ml.
The course of treatment is usually 25-30 injections. If necessary, it is carried out repeated treatment after 6 months. Doses of chondroitin sulfate, most frequently used in studies, usually reach 1200 mg per day.
Mukosat: Contraindications and side effects
The use of mucosate is contraindicated in patients that are supersensitive to the active substance. It is necessary to exclude the use of medication with manifestations of thrombophlebitis, as well as with bleeding.
At the place of administration, it is possible to develop bleeding and allergic reactions, in this case the question of removing the drug is raised. Side effects described as a result of using sulfate chondroitin are usually not large. The most commonly observed adverse reactions were manifested by epigastric pain, edema, nausea, and sometimes diarrhea.
Given the ability of the mucosate to perform potential anti -brototic activity, its use should be under strict medical supervision in patients receiving anticoagulant drugs, or patients suffering from coagulation disorders such as hemophilia.
During pregnancy and lactation of observation on the use of mucosate were not carried out.
Mukosat interaction with other drugs
Mukosat increases the effect of drugs that prevent thrombosis, the formation of prothrombin in the liver, as well as fibrinolytics. Therefore, you should use the drug with prudence and consulting a doctor. The price of the drug ranges from 620-740 rubles per package.
Video: Mukosat: Application
